Search clinical trials for: Influenza and COVID-19 Combination B

Total 1206 results

Zeev Rosberger

Completed

Exploring Changes in COVID-19 Vaccination Intentions by Prompting Altruistic Motives Using a Video Intervention

Vaccine Refusal

Canada
Mayo Clinic

Completed

Community-Engaged Bidirectional Pandemic Crisis and Emergency Risk Communication With COVID-19 Vaccine Messages to Minority Populations (CERC)

Vaccine Preventable Disease

United States
University of British Columbia
University of Utah; University of Virginia

Unknown

Enduring Happiness and Continued Self-Enhancement (ENHANCE) for COVID-19 (EN-COVID-19)

Well-Being

Canada
CNBG-Virogin Biotech (Shanghai) Ltd.

Recruiting

A PhaseⅡ Study to Evaluate the Safety and Immunogenicity of COVID-19 Vaccine

SARS-CoV-2 Infection

China
Johns Hopkins University
Integrated Research Center for Fetal Medicine

Recruiting

The Impact of COVID-19 on Maternal and Neonatal Outcomes

COVID-19 | Pregnancy; Infection

United States
China National Biotec Group Company Limited
Beijing Institute of Biological Products Co Ltd.; Hunan Provincial Center for...

Active, not recruiting

Study on Sequential Immunization of Omicron Inactivated COVID-19 Vaccine and Prototype Inactivated COVID-19 Vaccine in Population Aged 18 Years Old and Above (COVID-19)

COVID-19

China
Arizona State University

Enrolling by invitation

Back to ECE Safely With SAGE: Reducing COVID-19 Transmission in Hispanic and Low-income Preschoolers (BESAGE)

Exercise | Parents | Child Development | Diet, Healthy | COVID-19 Testing | Children, Preschool | Self-Control

United States
Dr. Soetomo General Hospital
Indonesia-MoH; Universitas Airlangga; Biotis Pharmaceuticals, Indonesia

Recruiting

UNAIR Inactivated COVID-19 Vaccine

Vaccine Reaction | COVID-19 Pandemic

Indonesia
Mark Loeb

Not yet recruiting

Fourth Dose of mRNA COVID-19 Vaccine in Residents of LTCFs

Coronavirus Infection | SARS-CoV2 Infection

Canada
National Vaccine and Serum Institute, China
China National Biotec Group Company Limited; Beijing Institute of Biological... and other collaborators

Recruiting

A Clinical Trial on Sequential Immunization of Recombinant COVID-19 Vaccine (CHO Cell, NVSI-06-09) and Inactivated COVID-19 Vaccine (Vero Cell)

COVID-19

United Arab Emirates
Abbott Rapid Dx

Completed

Sample Collection for Evaluation of the Panbio™ COVID-19/ Flu A&B Rapid Panel.

COVID-19 | Influenza A | Influenza Type B

United States
Oslo University Hospital
Age Labs AS

Recruiting

Risk Factors for Community- and Workplace Transmission of COVID-19

Coronavirus

Norway
WestVac Biopharma Co., Ltd.

Completed

A Clinical Trial of Immuno-bridging Between Different Manufacture Scales of Recombinant COVID-19 Vaccine (Sf9 Cell)

COVID-19 | SARS-CoV-2 Pneumonia

China
Priscilla Hsue, MD
San Francisco General Hospital; Blood Systems Research Institute

Completed

Effects of COVID-19 Convalescent Plasma (CCP) on Coronavirus-associated Complications in Hospitalized Patients (CAPRI)

COVID-19 | Sars-CoV2

United States
Spartan Bioscience Inc.
The Ottawa Hospital; Humber River Hospital

Completed

Spartan COVID-19 System: Evaluation of Clinical Sample Collection

Covid19

Canada
Texas Cardiac Arrhythmia Research Foundation

Unknown

Comparison of the Efficacy of Rapid Tests to Identify COVID-19 Infection (CATCh COVID-19) (CATCH COVID-19)

COVID-19

United States
Centro Medico ABC

Terminated

Treatment of Severe and Critical COVID-19 Pneumonia With Convalescent Plasma

Covid-19

Mexico
Sinocelltech Ltd.

Not yet recruiting

A Phase II Clinical Trial to Evaluate the Immunogenicity and Safety of SCTV01C in Population Aged ≥18 Years and Previously Fully Vaccinated With COVID-19 Vaccine

COVID-19 | SARS-CoV-2 Infection
Centre Hospitalier Universitaire de Saint Etienne

Active, not recruiting

Cohort Assessing the Immunogenicity and the Safety of the COVID-19 Vaccine Janssen in Healthy Volunteers Based on 2 Age Groups: 65 Years or Older - 55 to 65 Years. Covicompare-Janssen (CoviCompare_J)

Healthy Volunteers

France
VA Office of Research and Development
Minneapolis Veterans Affairs Medical Center; Central Arkansas Veterans Healthcare... and other collaborators

Active, not recruiting

Developing and Testing a COVID-19 Vaccination Acceptance Intervention (CoVAcS)

COVID-19 Vaccination

United States
Stanford University
University of California, San Francisco; Wuqu' Kawoq, Maya Health Alliance

Completed

Effectiveness of a Mayan Language Social Media Campaign on COVID-19 Vaccine Beliefs in Guatemala

Vaccination Refusal

Guatemala
Groupe d'Etude sur le Risque d'Exposition des Soignants...

Completed

Rapid Screening Test for Covid-19 Antibodies in Healthcare Workers

Covid-19 Immune Status of Healthcare Workers

France
Peking Union Medical College Hospital

Recruiting

COVID-19 Vaccine Effectiveness Against Recurrent Infection Among Lung Cancer Patients and Biomarker Research

Lung Cancer | Chemotherapy | Antibody | COVID-19 Recurrent | Vaccination | Immune Checkpoint Inhibitor

China
Monika Joshi

Completed

Coronavirus Disease 2019 (COVID-19) Vaccination in Cancer Patients

Malignancies Multiple

United States
Tanta University

Unknown

Differential Expression of Cytokines, Transcriptome and miRNA in Coronavirus Disease 2019 (COVID-19) Egyptian's Patients

Corona Virus Infection

Egypt
Hipra Scientific, S.L.U
National Institute of Hygiene and Epidemiology, Vietnam; Laboratorios Hipra...

Completed

Safety and Immunogenicity of Recombinant Protein RBD Fusion Dimer Vaccine Against the Virus That Cause COVID-19, Known as Severe Acute Respiratoy Syndrome Coronavirus 2 (SARS-CoV-2)

COVID-19 | SARS-CoV-2 Acute Respiratory Disease

Vietnam
Hipra Scientific, S.L.U
Laboratorios Hipra, S.A.

Completed

Immunogenicity and Safety of a Booster Vaccination With a Recombinant Protein RBD Candidate Vaccine Against SARS-CoV-2 in Healthy Adults Volunteers Fully Vaccinated Followed by an Extension Period to Study a Fourth Dose Administration.

COVID-19 | SARS-CoV-2 Acute Respiratory Disease

Spain
Butantan Institute
Sinovac Life Sciences Co., Ltd.

Completed

Clinical Trial of Efficacy and Safety of Sinovac's Adsorbed COVID-19 (Inactivated) Vaccine in Healthcare Professionals (PROFISCOV)

COVID-19

Brazil
Wuhan Rhegen Biotechnology Co., Ltd.
Shenzhen Rhegen Biotechnology Co., Ltd.; Wuhan Recogen Biotechnology Co., Ltd.

Withdrawn

A Phase 1, Randomised, Double-blinded, Placebo-controlled, Dose-escalation Study to Evaluate the Safety and Immunogenicity of RH109 as Booster

COVID-19 Pandemic
Damanhour University
Alexandria University

Completed

Assessment of Safety and Satisfaction Toward COVID-19 Vaccines.

COVID-19 Vaccine Adverse Reaction

Egypt
Stanford University
Viamo

Completed

Effectiveness of Interactive Voice Response for COVID-19 Vaccination Training in the Democratic Republic of the Congo

COVID-19 Vaccine Knowledge | COVID-19 Vaccine Beliefs

United States
Azienda Ospedaliera Universitaria Integrata Verona

Unknown

Evaluation of Immune Response in COVID-19 Patients (IMMUNOVID)

Infection Viral | Allergy and Immunology

Italy
Yisheng Biopharma (Singapore) Pte. Ltd.

Completed

A Phase I Study to Evaluate Safety, Tolerability, and Immunogenicity of a PIKA COVID-19 Vaccine in Healthy Individuals

COVID-19 Pandemic

United Arab Emirates
Diassess Inc.

Completed

Clinical Performance of the Diassess Influenza A and B Test

Influenza | Influenza, Human | Flu

United States
Ain Shams University

Recruiting

Evaluation of The Efficacy of Triazavirin Versus Oseltamivir in Egyptian Patients Infected With COVID-19 (COVID-19)

Covid19

Egypt
Ministerio de Salud de Ciudad Autónoma de Buenos...

Active, not recruiting

Strategies for Combining the First Component of Sputnik V With Other Adenoviral or mRNA-based Vaccines.

COVID-19 Vaccines

Argentina
Azienda Unità Sanitaria Locale Reggio Emilia
IRCCS San Raffaele; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University... and other collaborators

Recruiting

National Project on Vaccines, COVID-19 and Frail Patients (VAX4FRAIL)

COVID-19 | Hematologic Diseases | Rheumatic Diseases | Solid Tumor | Neurologic Disorder

Italy
Research Institute for Biological Safety Problems

Completed

Reactogenicity, Safety and Immunogenicity of QazCoVac-P COVID-19 Vaccine

Covid19 | Vaccine Adverse Reaction | SARS-CoV Infection

Kazakhstan
China National Biotec Group Company Limited
Beijing Institute of Biological Products Co Ltd.; Shulan (Hangzhou) Hospital

Active, not recruiting

A Study to Evaluate the Safety and Immunogenicity of Omicron COVID-19 Vaccine (Vero Cell), Inactivated in Population 18 Years Old of Age and Above (COVID-19)

COVID-19

China
Jiangsu Province Centers for Disease Control and...

Completed

The Phase I Clinical Trial of Booster Vaccination of Adenovirus Type-5 Vectored COVID-19 Vaccine

Adenovirus Type-5 Vectored COVID-19 Vaccine

China
Jiangsu Province Centers for Disease Control and...
West China Hospital

Withdrawn

Phase IIb Clinical Trial of Recombinant Novel Coronavirus Pneumonia (COVID-19) Vaccine (Sf9 Cells)

COVID-19

China
Azienda Ospedaliera San Paolo

Unknown

COST (COvid STudio) ACTION: Study for the Evaluation of Specific Antibodies Anti Covid-19 Linked to Covid-19 Infection, Symptoms and Genetic Expression of ACE2 Polymorphisms in Patients (COST ACTION) (COST ACTION)

COVID-19

Italy
National Research Center - Institute of Immunology...
St. Petersburg Research Institute of Vaccines and Sera

Completed

Evaluation of Safety & Efficacy of MIR 19 ® Inhalation Solution in Patients With Moderate COVID-19

COVID-19

Russian Federation
Research Institute for Biological Safety Problems
City polyclinic No. 4 of the of Almaty Ministry of Healthcare of the Republic... and other collaborators

Completed

Immunogenicity, Efficacy and Safety of QazCovid-in® COVID-19 Vaccine

Covid19 | Vaccine Adverse Reaction | SARS-CoV Infection

Kazakhstan
Sinocelltech Ltd.

Active, not recruiting

A Study to Evaluate the Immunogenicity and Safety of Two Recombinant Protein COVID-19 Vaccines in Population Aged ≥18 Years as Booster Vaccines

COVID-19 | SARS-CoV-2 Infection

United Arab Emirates
University of Milano Bicocca

Completed

Frailty in Elderly Patients With COVID-19 (FRA-COVID)

Covid19

Italy
Hospital Italiano de Buenos Aires

Completed

Convalescent Plasma and Placebo for the Treatment of COVID-19 Severe Pneumonia (PLASM-AR)

COVID-19 | SARS-CoV-2 | SARS Virus

Argentina
Centro Studi Internazionali, Italy
VivaChek Laboratories, Inc.

Unknown

Clinical Performance of the VivaDiag ™ COVID-19 lgM / IgG Rapid Test in Early Detecting the Infection of COVID-19

Coronavirus Infections

Italy
Northwestern University
Boston Children's Hospital; Brigham and Women's Hospital; Boston Medical Center

Recruiting

Vaccine Hesitancy in Black/African Americans With Rheumatic Diseases

COVID-19 | Rheumatic Diseases | COVID-19 Vaccine | SLE

United States
WestVac Biopharma Co., Ltd.
WestVac Biopharma (Guangzhou) Co., Ltd.

Recruiting

A Phase 3 Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of Booster Vaccination With Recombinant COVID-19 (XBB) Trimer Protein Vaccine (Sf9 Cell)

COVID-19

China

Search clinical trials for: Influenza and COVID-19 Combination B

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Peru

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations